I ran into this Wired article that tells the interesting story of the Pfizer failure in launching torcetrapib, a potentially revolutionary compound for cardiovascular treatment. Although the conclusion is too skeptical and the article gets a little bit lost on the “correlation vs. causation” argument, I believe it’s a good example of what can happen when people become … [Read more...] about Randomized Control Trials vs. Structural models: sometimes a question of life or death (and millions of dollars….)
